Ana Ruiz-Sáenz

704 total citations
20 papers, 483 citations indexed

About

Ana Ruiz-Sáenz is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Ana Ruiz-Sáenz has authored 20 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Ana Ruiz-Sáenz's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (7 papers) and CAR-T cell therapy research (3 papers). Ana Ruiz-Sáenz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (7 papers) and CAR-T cell therapy research (3 papers). Ana Ruiz-Sáenz collaborates with scholars based in United States, Netherlands and Spain. Ana Ruiz-Sáenz's co-authors include Mark M. Moasser, Miguel A. Alonso, Isabel Correas, Marcia R. Campbell, Veronica Steri, Courtney A. Dreyer, Jaime Millán, Leonor Kremer, Danislav S. Spassov and Amit S. Piple and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Nature Cell Biology.

In The Last Decade

Ana Ruiz-Sáenz

20 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Ruiz-Sáenz United States 14 266 157 110 81 71 20 483
Hong‐Jun Liao United States 8 308 1.2× 162 1.0× 100 0.9× 87 1.1× 50 0.7× 11 485
Blandine Deux France 5 267 1.0× 150 1.0× 77 0.7× 59 0.7× 42 0.6× 6 419
Jasminka Omerović United Kingdom 10 410 1.5× 183 1.2× 116 1.1× 58 0.7× 52 0.7× 11 553
Jessica B. Casaletto United States 6 311 1.2× 118 0.8× 144 1.3× 38 0.5× 43 0.6× 7 498
Hong-Jen Lee Taiwan 8 468 1.8× 182 1.2× 69 0.6× 48 0.6× 61 0.9× 8 608
Thomas Frogne Denmark 9 313 1.2× 217 1.4× 92 0.8× 69 0.9× 28 0.4× 11 557
Mattia Falcone Netherlands 9 220 0.8× 110 0.7× 76 0.7× 27 0.3× 55 0.8× 13 374
Szabolcs Sipeki Hungary 11 316 1.2× 92 0.6× 95 0.9× 31 0.4× 71 1.0× 14 470
Xiumei Cai China 14 342 1.3× 95 0.6× 76 0.7× 31 0.4× 57 0.8× 21 486
William J. Muller Canada 5 437 1.6× 209 1.3× 57 0.5× 60 0.7× 63 0.9× 5 622

Countries citing papers authored by Ana Ruiz-Sáenz

Since Specialization
Citations

This map shows the geographic impact of Ana Ruiz-Sáenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Ruiz-Sáenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Ruiz-Sáenz more than expected).

Fields of papers citing papers by Ana Ruiz-Sáenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Ruiz-Sáenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Ruiz-Sáenz. The network helps show where Ana Ruiz-Sáenz may publish in the future.

Co-authorship network of co-authors of Ana Ruiz-Sáenz

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Ruiz-Sáenz. A scholar is included among the top collaborators of Ana Ruiz-Sáenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Ruiz-Sáenz. Ana Ruiz-Sáenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruiz-Sáenz, Ana, et al.. (2025). ADCC: the rock band led by therapeutic antibodies, tumor and immune cells. Frontiers in Immunology. 16. 1548292–1548292. 6 indexed citations
2.
3.
Campbell, Marcia R., Ana Ruiz-Sáenz, Yuntian Zhang, et al.. (2022). Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling. Cell Reports. 38(5). 110285–110285. 13 indexed citations
4.
Campbell, Marcia R., Ana Ruiz-Sáenz, Christopher Agnew, et al.. (2022). Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers. Cell Reports. 38(5). 110291–110291. 15 indexed citations
5.
Ruiz-Sáenz, Ana, Farima Zahedi, Courtney A. Dreyer, et al.. (2021). Proteomic Analysis of Src Family Kinase Phosphorylation States in Cancer Cells Suggests Deregulation of the Unique Domain. Molecular Cancer Research. 19(6). 957–967. 9 indexed citations
6.
Badr, Christian E., Ana Ruiz-Sáenz, Jeffrey Serrill, et al.. (2020). Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A. Biochemical Pharmacology. 183. 114317–114317. 18 indexed citations
7.
Coppé, Jean‐Philippe, Miki Mori, Bo Pan, et al.. (2019). Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities. Nature Cell Biology. 21(6). 778–790. 26 indexed citations
8.
Ruiz-Sáenz, Ana, et al.. (2018). HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3. Cancer Research. 78(13). 3645–3658. 103 indexed citations
9.
Spassov, Danislav S., Ana Ruiz-Sáenz, Amit S. Piple, & Mark M. Moasser. (2018). A Dimerization Function in the Intrinsically Disordered N-Terminal Region of Src. Cell Reports. 25(2). 449–463.e4. 40 indexed citations
10.
Ruiz-Sáenz, Ana & Mark M. Moasser. (2018). Targeting HER2 by Combination Therapies. Journal of Clinical Oncology. 36(8). 808–811. 14 indexed citations
11.
Campbell, Marcia R., Hui Zhang, Ana Ruiz-Sáenz, et al.. (2016). Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin. Breast Cancer Research and Treatment. 155(3). 431–440. 15 indexed citations
12.
Ruiz-Sáenz, Ana, et al.. (2016). Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum. European Journal of Cancer. 61. S131–S131. 7 indexed citations
13.
Ruiz-Sáenz, Ana, et al.. (2016). Alternative polyadenylation in a family of paralogousEPB41genes generates protein 4.1 diversity. RNA Biology. 14(2). 236–244. 5 indexed citations
14.
Ruiz-Sáenz, Ana, Manbir Sandhu, Y. Carrasco, et al.. (2015). Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum. Oncogene. 34(41). 5288–5294. 23 indexed citations
15.
16.
Ruiz-Sáenz, Ana, Jeffrey van Haren, Carmen Laura Sayas, et al.. (2013). Protein 4.1R binds to CLASP2 and regulates dynamics, organization and attachment of microtubules to the cell cortex. Journal of Cell Science. 126(Pt 20). 4589–601. 16 indexed citations
17.
Aranda, Juan, Natalia Reglero-Real, Beatriz Marcos‐Ramiro, et al.. (2012). MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression. Molecular Biology of the Cell. 24(4). 483–494. 33 indexed citations
18.
Andrés‐Delgado, Laura, Olga M. Antón, Francesca Bartolini, et al.. (2012). INF2 promotes the formation of detyrosinated microtubules necessary for centrosome reorientation in T cells. The Journal of Cell Biology. 198(6). 1025–1037. 65 indexed citations
19.
Ruiz-Sáenz, Ana, Leonor Kremer, Miguel A. Alonso, Jaime Millán, & Isabel Correas. (2011). Protein 4.1R regulates cell migration and IQGAP1 recruitment to the leading edge. Journal of Cell Science. 124(15). 2529–2538. 27 indexed citations
20.
Aranda, Juan, Natalia Reglero-Real, Leonor Kremer, et al.. (2011). MYADM regulates Rac1 targeting to ordered membranes required for cell spreading and migration. Molecular Biology of the Cell. 22(8). 1252–1262. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong‐Jun Liao Breakdown of academic impact, for papers by Blandine Deux Breakdown of academic impact, for papers by Jasminka Omerović Breakdown of academic impact, for papers by Jessica B. Casaletto Breakdown of academic impact, for papers by Hong-Jen Lee Breakdown of academic impact, for papers by Thomas Frogne Breakdown of academic impact, for papers by Mattia Falcone Breakdown of academic impact, for papers by Szabolcs Sipeki Breakdown of academic impact, for papers by Xiumei Cai Breakdown of academic impact, for papers by William J. Muller
Rankless by CCL
2026